Press Releases Nov 01, 2023 Innoviva Reports Third Quarter 2023 Financial Results and Highlights Recent Company Progress Nov 01, 2023 Positive Results Announced in Largest Pivotal Phase 3 Trial of a First-in-Class Oral Antibiotic to Treat Uncomplicated Gonorrhea Sep 19, 2023 Innoviva to Participate in the Cantor Global Healthcare Conference View all press releases Presentations & Events View all presentations & events Form 8937 View Form 8937 - September 30, 2015 View Form 8937
Nov 01, 2023 Innoviva Reports Third Quarter 2023 Financial Results and Highlights Recent Company Progress
Nov 01, 2023 Positive Results Announced in Largest Pivotal Phase 3 Trial of a First-in-Class Oral Antibiotic to Treat Uncomplicated Gonorrhea